ERBB2 and breast cancer: The cumulative incidence of BM (two years after initial diagnosis of BC) was 26.6% (192/722) for ER+ patients and 34.4% (87/253) for ER-Her2-patients; however, it was 42.0% (79/188) for Her2+ patients (Figure 5B).